InvestorInvesting in private markets for over 30 years.

Droia Ventures is a specialist biotech investor based in Brussels, Belgium, focusing on therapeutics for oncology and genetic diseases. The firm actively supports early-stage drug development companies globally, leveraging innovative science and technology.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Droia Ventures, founded in 2021, is a specialist biotech investor based in Brussels, Belgium. The firm manages over $750 million in investments and focuses on therapeutics for oncology and genetic diseases. Droia Ventures targets early-stage drug development companies that utilize novel science and innovative technologies. The organization emphasizes a hands-on investment approach, actively supporting portfolio companies from creation through clinical proof of concept. Notable portfolio companies include Accent Therapeutics, Actio Biosciences, and Alesta Therapeutics. Droia Ventures has also launched the Droia Genetic Disease Fund, aiming to raise €220 million for early-stage biotech companies developing therapeutics for genetic diseases.
Droia Ventures exclusively invests in therapeutics targeting oncology and genetic diseases. The firm seeks to support companies that tackle previously unsolvable clinical problems through innovative technology platforms or scientific insights, emphasizing significant patient benefits and improvements over existing standard care.
Droia Ventures adds value to its portfolio companies through hands-on support, leveraging its expertise in drug development and access to a network of industry contacts. The firm emphasizes collaboration and strategic guidance from company creation through clinical proof of concept, ensuring that its investments are well-positioned for success.
Droia Ventures invests in early-stage drug development companies focused on therapeutics for oncology and genetic diseases. The firm looks for innovative technology platforms and scientific insights that address previously unsolvable clinical problems.
Founders can pitch their ideas through the firm's website at droiaventures.com. It is recommended to include a detailed business plan and information on the technology being developed.
Droia Ventures emphasizes hands-on support from company creation through clinical proof of concept. The firm leverages its expertise in drug development and access to a network of industry contacts to enhance the success of its portfolio companies.
The firm operates globally, with a strong presence in both North America and Europe, allowing it to tap into diverse markets and foster advancements in healthcare.
Droia Ventures invests in a range of funding rounds, typically starting from early-stage funding to larger rounds, depending on the needs of the portfolio companies.
The firm provides ongoing support to its portfolio companies, including strategic guidance, operational support, and access to its extensive network, ensuring that companies are well-positioned for success.
Superscout Pro
Is this page right?Reviewed · How the research works